SCAR02
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCAR02, covering 2025-04-24 to 2025-04-24. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases [NA]